SKI Market

Indian Indices

Sensex

83,570.35 187.64
( 0.23%)

Global Indices

Nasdaq

49,379.59 -83.86
(-0.17%)

Dow Jones

6,960.70 -4.77
(-0.07%)

Hang Seng

53,996.71 -113.79
(-0.21%)

Nikkei 225

10,219.48 -19.46
(-0.19%)

Forex

USD-INR

90.32 0.07
(0.08%)

EUR-INR

104.98 -0.13
(-0.12%)

GBP-INR

121.10 -0.20
(-0.16%)

JPY-INR

0.57 0.00
(0.21%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Astrazeneca Pharma India Ltd

Industry : Pharmaceuticals - Multinational

BSE Code

ISIN Demat

Book Value()

506820

INE203A01020

319.6

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ASTRAZEN

89.24

20629.88

EPS(TTM)

Face Value()

Div & Yield %

92.47

0.39

Back

TCM reports standalone net loss of Rs 0.31 crore in the September 2025 quarter

Nov 11,2025

Net Loss of TCM reported to Rs 0.31 crore in the quarter ended September 2025 as against net loss of Rs 0.19 crore during the previous quarter ended September 2024. Sales declined 22.65% to Rs 5.02 crore in the quarter ended September 2025 as against Rs 6.49 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	5.02	6.49	-23
OPM %	-8.37	-4.62	-
PBDT	-0.25	-0.17	-47
PBT	-0.31	-0.19	-63
NP	-0.31	-0.19	-63

83,570.35 187.64 ( 0.23%)

49,379.59 -83.86 (-0.17%)

6,960.70 -4.77 (-0.07%)

53,996.71 -113.79 (-0.21%)

10,219.48 -19.46 (-0.19%)

90.32 0.07 (0.08%)

104.98 -0.13 (-0.12%)

121.10 -0.20 (-0.16%)

0.57 0.00 (0.21%)